Stay updated on PF-06438179 vs. Infliximab Pharmacokinetics Clinical Trial
Sign up to get notified when there's something new on the PF-06438179 vs. Infliximab Pharmacokinetics Clinical Trial page.

Latest updates to the PF-06438179 vs. Infliximab Pharmacokinetics Clinical Trial page
- CheckyesterdayChange DetectedA Locations section now lists Kansas as a site, replacing the previous Kansas Locations label; the page shows revision v3.3.3 and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe Publications note on the study record was updated to indicate automatic population from PubMed. The revision tag was updated to v3.3.2.SummaryDifference0.1%

- Check37 days agoChange DetectedRemoved a site-wide government funding status notice; this does not affect the study details or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check51 days agoChange DetectedThe new screenshot shows only minor UI/layout tweaks on the Study Details page and no changes to core content such as eligibility criteria, interventions, or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check80 days agoChange DetectedUpdated the page to v3.2.0 with a prominent notice about potential data/tansaction delays due to funding gaps and where to check operating status; previous v3.1.0 reference removed.SummaryDifference5%

- Check87 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.1%

Stay in the know with updates to PF-06438179 vs. Infliximab Pharmacokinetics Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-06438179 vs. Infliximab Pharmacokinetics Clinical Trial page.